Evaluation of warfarin management in primary health care centers in Qatar : A retrospective cross-sectional analysis of the national dataset
Copyright © 2024. Published by Elsevier Inc..
BACKGROUND: Warfarin management is associated with severe complications, highlighting the critical need to evaluate the quality of its administration.
OBJECTIVES: To evaluate the quality of warfarin management for patients managed in primary healthcare centers by measuring the percentage of Time in Therapeutic Range (TTR) and the proportion of extreme out-of-range international normalized ratio (INR) values.
METHODS: This is a cross-sectional study. Data was extracted from a national dataset retrieved from the largest primary healthcare provider in Qatar. TTR was calculated using the traditional method. Inferential and descriptive analyses were performed as appropriate.
RESULTS: Four hundred ninety-four patients met the inclusion criteria. The mean (SD) TTR was 45.3 % (17.5). This was significantly lower than the recommended cutoff value (P<0.001). Extreme out-of-range INR accounted for 24.7 % of total INR readings.
CONCLUSIONS: The management of patients taking warfarin in Qatar is inadequate. More effective strategies are warranted to ensure safe and effective therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
|---|---|
| Enthalten in: |
Current problems in cardiology - 49(2024), 4 vom: 31. März, Seite 102427 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Alshihab, Safaa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
5Q7ZVV76EI |
|---|
| Anmerkungen: |
Date Completed 04.03.2024 Date Revised 04.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cpcardiol.2024.102427 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367912856 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367912856 | ||
| 003 | DE-627 | ||
| 005 | 20240304232410.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240202s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cpcardiol.2024.102427 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1316.xml |
| 035 | |a (DE-627)NLM367912856 | ||
| 035 | |a (NLM)38301919 | ||
| 035 | |a (PII)S0146-2806(24)00066-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Alshihab, Safaa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evaluation of warfarin management in primary health care centers in Qatar |b A retrospective cross-sectional analysis of the national dataset |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.03.2024 | ||
| 500 | |a Date Revised 04.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024. Published by Elsevier Inc. | ||
| 520 | |a BACKGROUND: Warfarin management is associated with severe complications, highlighting the critical need to evaluate the quality of its administration | ||
| 520 | |a OBJECTIVES: To evaluate the quality of warfarin management for patients managed in primary healthcare centers by measuring the percentage of Time in Therapeutic Range (TTR) and the proportion of extreme out-of-range international normalized ratio (INR) values | ||
| 520 | |a METHODS: This is a cross-sectional study. Data was extracted from a national dataset retrieved from the largest primary healthcare provider in Qatar. TTR was calculated using the traditional method. Inferential and descriptive analyses were performed as appropriate | ||
| 520 | |a RESULTS: Four hundred ninety-four patients met the inclusion criteria. The mean (SD) TTR was 45.3 % (17.5). This was significantly lower than the recommended cutoff value (P<0.001). Extreme out-of-range INR accounted for 24.7 % of total INR readings | ||
| 520 | |a CONCLUSIONS: The management of patients taking warfarin in Qatar is inadequate. More effective strategies are warranted to ensure safe and effective therapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Anticoagulants | |
| 650 | 4 | |a Primary health care | |
| 650 | 4 | |a Time in therapeutic range | |
| 650 | 4 | |a Warfarin | |
| 650 | 7 | |a Warfarin |2 NLM | |
| 650 | 7 | |a 5Q7ZVV76EI |2 NLM | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 700 | 1 | |a Mohamed Ibrahim, Mohamed Izham |e verfasserin |4 aut | |
| 700 | 1 | |a Hadi, Muhammad Abdul |e verfasserin |4 aut | |
| 700 | 1 | |a Syed, Abdullah |e verfasserin |4 aut | |
| 700 | 1 | |a Arabi, Abdulrahman |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Qahtani, Awad |e verfasserin |4 aut | |
| 700 | 1 | |a Almujalli, Hanan |e verfasserin |4 aut | |
| 700 | 1 | |a Rafie, Ihsan |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Kuwari, Mohamed Gaith |e verfasserin |4 aut | |
| 700 | 1 | |a Kandy, Mujeeb |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Zaidan, Manal |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current problems in cardiology |d 1993 |g 49(2024), 4 vom: 31. März, Seite 102427 |w (DE-627)NLM000219622 |x 1535-6280 |7 nnns |
| 773 | 1 | 8 | |g volume:49 |g year:2024 |g number:4 |g day:31 |g month:03 |g pages:102427 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cpcardiol.2024.102427 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 49 |j 2024 |e 4 |b 31 |c 03 |h 102427 | ||